Your browser doesn't support javascript.
loading
Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III study.
Chen, Likun; Rangel, Jose David Gomez; Cil, Timucin; Li, Xingya; Cicin, Irfan; Shen, Yihong; Liu, Zhihua; Ozyilkan, Ozgur; Igor, Bondarenko; Chen, Jun; Oleksandr, Kostiuk; Chen, Zhendong; Zhang, Helong; Fu, Ziyi; Dong, Qingfeng; Song, Shuqiang; Yu, Jin-Chen; Zhang, Li.
Afiliação
  • Chen L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangdong, Guangzhou, China.
  • Rangel JDG; Clinical Medical Research S.C, Veracruz, México.
  • Cil T; Health and Science University, Adana City Education and Research Hospital, Adana, Turkey.
  • Li X; The First Affiliated Hospital of Zhengzhou University, Henan, Zhengzhou, China.
  • Cicin I; Trakya University Medical Faculty, Edirne, Turkey.
  • Shen Y; The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
  • Liu Z; Jiangxi Cancer Hospital, Jiangxi, Nanchang, China.
  • Ozyilkan O; Baskent University Adana Application and Research Center, Adana, Turkey.
  • Igor B; CNE "City Clinical Hospital No4", Dnipro, Ukraine.
  • Chen J; Tianjin Medical University General Hospital, Tianjin, China.
  • Oleksandr K; Podilskyi Regional Oncological Center, Vinnytsia, Ukraine.
  • Chen Z; The Second Hospital of Anhui Medical University, Anhui, Hefei, China.
  • Zhang H; Tangdu Hospital, Fourth Military Medical University, Shanxi, Xi'an, China.
  • Fu Z; Bio-Thera Solutions, Ltd., Guangdong, Guangzhou, China.
  • Dong Q; Bio-Thera Solutions, Ltd., Guangdong, Guangzhou, China.
  • Song S; Bio-Thera Solutions, Ltd., Guangdong, Guangzhou, China.
  • Yu JC; Bio-Thera Solutions, Ltd., Guangdong, Guangzhou, China.
  • Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangdong, Guangzhou, China.
Cancer Med ; 12(22): 20847-20863, 2023 11.
Article em En | MEDLINE | ID: mdl-37935428

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Medicamentos Biossimilares / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Medicamentos Biossimilares / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article